Flavopiridol suppresses the activation of NLRP3 inflammasome induced by palmitate and improves obesity-related inflammation and insulin resistance through inducing macrophage autophagy (130). The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.